Today, the Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released a new report on the best practices in state bioscience economic development measures, “The U.S. Biosciences Industry in the States: Best Practices in Innovation, Partnerships, and Job Creation.”Continue reading
Author Archive: AZBio
BIO-backed bills that would support startups passed by House
Two bills to create a healthy investment environment for biotech startups passed the House late May 30 with overwhelming bipartisan support. The legislation was also supported by the Biotechnology Innovation Organization (BIO).
Continue reading
ABRC Request for Grant Applications Now Open
The Arizona Biomedical Research Centre announced today that it is now accepting Letters of Intent (LOI) for a new cohort of research grants. The LOI is Phase One of a two-phase process. LOI will be accepted through June 28, 2023. Once the letters are reviewed and scored, select applicants will be invited to submit a full application.Continue reading
Five UArizona Health Sciences researchers selected for Career Development Awards
The University of Arizona Health Sciences Career Development Awards program supports the development of new research by promising young investigators. Five junior faculty members beginning independent research projects are receiving funding through the University of Arizona Health Sciences Career Development Award program.Continue reading
Arizona Board of Regents announces university-led statewide effort to address critical health care workforce shortages
Today, the Arizona Board of Regents announced a comprehensive, university-led statewide effort to address critical workforce shortages among physicians, nurses and other health care professionals. Currently, it is estimated nearly 3 million Arizonans have limited access to primary care, and more than one in three Arizona hospitals face a critical staffing shortage.Continue reading
Patients will lose access to 40% of future medicines because of the IRA, new research finds.
New research released by Vital Transformation (VT) shows that the Inflation Reduction Act (IRA) will stifle the ability of companies to continue research and development across a broad range of therapeutic areas. The effects of the IRA will have a far more serious impact on the development of new medicines than has been reported, according to the research.Continue reading
CEI Offers Course on Creating Your Quality Management System (QMS)
Get an overview of quality systems and understand the what and why founders need to know.Continue reading
GT Medical Technologies Marks a Clinical Milestone: 200th Patient Enrolled in the Multicenter Observational Registry of GammaTile® Therapy
Registry Study of GammaTile Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain NeoplasmsContinue reading
KOL Conversation: The Impact of the IRA on Oncology Patient Care
Impact of the IRA on Oncology Patient Care features an interview with Dr. Barbara L. McAneny, MD, FASCO, MACP Former President for the American Medical Association and the New Mexico Medical Society (NMMS); and currently CEO, New Mexico Cancer Center.
With Dr. Steve Potts CEO, Anticipate Bioscience.
Impact of the IRA on Oncology Patient Care was recorded on the 26th of May 2023Continue reading